|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP3653212B1
(en)
|
2012-12-20 |
2023-04-26 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP2997134B1
(en)
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
WO2014190273A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
US9725710B2
(en)
|
2014-01-08 |
2017-08-08 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
CN106414748B
(zh)
|
2014-02-14 |
2021-05-28 |
得克萨斯州大学系统董事会 |
嵌合抗原受体及制备方法
|
|
ES2995052T3
(en)
|
2014-04-23 |
2025-02-05 |
Juno Therapeutics Inc |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
FR3026744B1
(fr)
|
2014-10-06 |
2024-04-19 |
Hopitaux Paris Assist Publique |
Methode de generation de progeniteurs de cellules t
|
|
US10570186B2
(en)
|
2014-11-05 |
2020-02-25 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (CAR) to selectively target protein complexes
|
|
WO2016100232A1
(en)
|
2014-12-15 |
2016-06-23 |
The Regents Of The University Of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
US10808230B2
(en)
|
2015-02-24 |
2020-10-20 |
Board Of Regents, The University Of Texas System |
Selection methods for genetically-modified T cells
|
|
US10570382B2
(en)
|
2015-03-11 |
2020-02-25 |
Board Of Regents, The University Of Texas System |
Transposase polypeptides and uses thereof
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
IL295616A
(en)
|
2015-07-31 |
2022-10-01 |
Us Health |
Adapted cells and treatment methods
|
|
CA2994412A1
(en)
|
2015-07-31 |
2017-02-09 |
Memorial Sloan-Kettering Cancer Center |
Antigen-binding proteins targeting cd56 and uses thereof
|
|
WO2017048902A1
(en)
|
2015-09-15 |
2017-03-23 |
Board Of Regents, The University Of Texas System |
T-cell receptor (tcr)-binding antibodies and uses thereof
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
US11197919B2
(en)
*
|
2015-11-04 |
2021-12-14 |
City Of Hope |
Chimeric antigen receptors targeting HER2
|
|
MX2018005825A
(es)
*
|
2015-11-09 |
2019-07-04 |
Aperisys Inc |
Celulas inmunes modificadas y usos de las mismas.
|
|
WO2017132535A1
(en)
*
|
2016-01-28 |
2017-08-03 |
The Regents Of The University Of California |
Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating hiv infection
|
|
KR20180105709A
(ko)
|
2016-02-05 |
2018-09-28 |
시티 오브 호프 |
중추 신경계의 암의 치료를 위한 조작된 t 세포의 투여
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
WO2017184968A1
(en)
*
|
2016-04-22 |
2017-10-26 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
JP7070932B2
(ja)
*
|
2016-06-06 |
2022-05-18 |
シティ・オブ・ホープ |
Ｂａｆｆ－ｒ標的化キメラ抗原受容体修飾ｔ細胞及びその使用
|
|
US20200208111A1
(en)
*
|
2016-06-09 |
2020-07-02 |
Branden S. Moriarity |
Genome-edited nk cell and methods of making and using
|
|
CN107523547A
(zh)
*
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
WO2017223557A1
(en)
*
|
2016-06-24 |
2017-12-28 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Genetic re-engineering of immune cells to improve metabolic fitness for immunotherapy
|
|
CN107663240B
(zh)
*
|
2016-07-29 |
2021-01-12 |
中国人民解放军第四军医大学 |
高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用
|
|
CA3034691A1
(en)
|
2016-08-30 |
2018-03-08 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
|
KR20190127655A
(ko)
|
2016-10-19 |
2019-11-13 |
프로디자인 소닉스, 인크. |
음향학에 의한 친화성 세포 추출
|
|
CN110121505B
(zh)
|
2016-12-28 |
2023-08-01 |
株式会社绿十字细胞治疗 |
嵌合抗原受体和表达其的自然杀伤细胞
|
|
BR112019016672A8
(pt)
|
2017-02-13 |
2022-11-22 |
Hopitaux Paris Assist Publique |
Método para gerar progenitores de células t
|
|
ES3010559T3
(en)
|
2017-02-28 |
2025-04-03 |
Endocyte Inc |
Compositions and methods for car t cell therapy
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
IL270415B2
(en)
|
2017-05-12 |
2024-08-01 |
Crispr Therapeutics Ag |
Materials and methods for cell engineering and their uses in immuno-oncology
|
|
CN107099603A
(zh)
*
|
2017-05-31 |
2017-08-29 |
成都克里斯博生物科技有限公司 |
肿瘤免疫t细胞检测试剂盒和检测方法
|
|
GB201709203D0
(en)
*
|
2017-06-09 |
2017-07-26 |
Autolus Ltd |
Antigen-binding domain
|
|
EP3651795A4
(en)
*
|
2017-07-12 |
2021-05-26 |
The Board of Trustees of the Leland Stanford Junior University |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERS PRESENT A H3K27M MUTATION
|
|
CN111432823A
(zh)
*
|
2017-07-25 |
2020-07-17 |
得克萨斯大学体系董事会 |
增强的嵌合抗原受体及其用途
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
CN107287165A
(zh)
*
|
2017-08-23 |
2017-10-24 |
湖南开启时代生物科技有限责任公司 |
一种car‑t细胞的制备方法
|
|
US20200261502A1
(en)
*
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
CR20240302A
(es)
|
2017-09-29 |
2024-11-07 |
Us Health |
Receptores de células t que reconocen p53 mutado (divisional exp. 2020-0170)
|
|
CN107488738B
(zh)
*
|
2017-10-12 |
2020-04-28 |
中国医学科学院肿瘤医院 |
一种预测乳腺癌对曲妥珠单抗联合化疗治疗敏感性的生物标志物
|
|
CN111601823B
(zh)
|
2017-11-07 |
2024-09-24 |
德克萨斯大学体系董事会 |
用car-t或car-nk细胞在癌症治疗中靶向lilrb4
|
|
AU2018370195B2
(en)
|
2017-11-14 |
2022-01-13 |
Green Cross Lab Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
CA3082334A1
(en)
*
|
2017-11-20 |
2019-05-23 |
Julius-Maximilians-Universitat Wurzburg |
Cd19cart cells eliminate myeloma cells that express very low levels of cd19
|
|
CU24558B1
(es)
*
|
2017-11-28 |
2021-12-08 |
Ct Inmunologia Molecular |
Anticuerpos monoclonales que reconocen al receptor del factor de crecimiento epidérmico y sus fragmentos derivados
|
|
CN108070033A
(zh)
*
|
2017-12-12 |
2018-05-25 |
武汉波睿达生物科技有限公司 |
一种3bnc-car分子的构建及其在杀灭hiv-1感染细胞中的应用
|
|
JP2021507561A
(ja)
|
2017-12-14 |
2021-02-22 |
フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． |
音響トランスデューサドライバ及びコントローラ
|
|
SG11202005609PA
(en)
*
|
2017-12-15 |
2020-07-29 |
Univ Leland Stanford Junior |
Compositions and methods for inhibiting t cell exhaustion
|
|
MY202687A
(en)
*
|
2017-12-23 |
2024-05-15 |
Uwell Biopharma Inc |
Pharmaceutical chimeric receptor composition and method thereof
|
|
CA3086832A1
(en)
|
2018-01-03 |
2019-07-11 |
Qu Biologics Inc. |
Innate targeting of adoptive cellular therapies
|
|
US11965191B2
(en)
|
2018-01-18 |
2024-04-23 |
California Institute Of Technology |
Programmable protein circuits in living cells
|
|
AU2019209428B2
(en)
*
|
2018-01-22 |
2025-06-26 |
Endocyte, Inc. |
Methods of use for CAR T cells
|
|
WO2019147604A2
(en)
*
|
2018-01-23 |
2019-08-01 |
Vanderbilt University |
Self-antigen specific t-cells as vacines for augmenting engraftment and stability of autologous transfer
|
|
CA3090089A1
(en)
|
2018-02-06 |
2019-08-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
TW202000229A
(zh)
|
2018-02-23 |
2020-01-01 |
美商安德賽特公司 |
Car t細胞療法之順序方法
|
|
SG11202008261WA
(en)
*
|
2018-03-08 |
2020-09-29 |
Rubius Therapeutics Inc |
Therapeutic cell systems and methods for treating cancer and infectious diseases
|
|
US20190247437A1
(en)
*
|
2018-04-19 |
2019-08-15 |
APDN (B.V.I.), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
WO2019215500A1
(en)
|
2018-05-11 |
2019-11-14 |
Crispr Therapeutics Ag |
Methods and compositions for treating cancer
|
|
AU2019301070B2
(en)
|
2018-07-09 |
2025-09-11 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
US20210308267A1
(en)
*
|
2018-08-07 |
2021-10-07 |
Purdue Research Foundation |
Rejuvenation of car t cell
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
EP3844180A4
(en)
|
2018-08-31 |
2022-07-20 |
California Institute of Technology |
Synthetic protein circuits detecting signal transducer activity
|
|
AU2019336229A1
(en)
*
|
2018-09-07 |
2021-03-18 |
Sotio, LLC |
Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
|
|
JP2022512594A
(ja)
*
|
2018-10-05 |
2022-02-07 |
ザンクト アンナ キンダークレプスフォルシュング |
キメラ抗原受容体（ｃａｒ）の群
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
WO2020146627A1
(en)
|
2019-01-10 |
2020-07-16 |
California Institute Of Technology |
A synthetic system for tunable thresholding of protein signals
|
|
WO2020154617A1
(en)
*
|
2019-01-25 |
2020-07-30 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting mutant ras
|
|
WO2020163682A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
MX2021009506A
(es)
*
|
2019-02-08 |
2021-09-08 |
Biontech Cell & Gene Therapies Gmbh |
Tratamiento que implica celulas t modificadas con car y citoquinas.
|
|
KR20210129105A
(ko)
|
2019-02-15 |
2021-10-27 |
에디타스 메디신, 인코포레이티드 |
면역치료법을 위한 변형된 자연 살해(nk) 세포
|
|
JP7593646B2
(ja)
|
2019-02-20 |
2024-12-03 |
シティ・オブ・ホープ |
Ｂａｆｆ－ｒ／ｃｄ１９を標的としたキメラ抗原受容体修飾ｔ細胞とその使用
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
US20220249558A1
(en)
|
2019-04-30 |
2022-08-11 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19
|
|
CA3139965A1
(en)
*
|
2019-06-07 |
2020-12-10 |
Ivie AIFUWA |
Automated t cell culture
|
|
WO2020247837A1
(en)
*
|
2019-06-07 |
2020-12-10 |
The Trustees Of The University Of Pennsylvania |
Dual car expressing t cells individually linked to cd28 and 4-1bb
|
|
EP4028413A1
(en)
|
2019-09-10 |
2022-07-20 |
Obsidian Therapeutics, Inc. |
Ca2-il15 fusion proteins for tunable regulation
|
|
CN120605327A
(zh)
*
|
2019-11-06 |
2025-09-09 |
贝勒医学院 |
用于产生细胞毒性效应子记忆t细胞以用于癌症的t细胞治疗的方法
|
|
KR20220128988A
(ko)
*
|
2019-11-27 |
2022-09-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
항-cd3 scfv 및 사이토카인 생산용 인공 항원 제시 세포
|
|
AU2020401315B2
(en)
*
|
2019-12-11 |
2023-11-09 |
A2 Biotherapeutics, Inc. |
LILRB1-based chimeric antigen receptor
|
|
EP4100428A4
(en)
|
2020-02-04 |
2024-03-06 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
CHIMERIC ANTI-DINITROPHENOL ANTIGEN RECEPTORS
|
|
TW202146431A
(zh)
*
|
2020-02-25 |
2021-12-16 |
英商圭爾醫療有限公司 |
用於經工程化細胞之嵌合受體
|
|
CN111253493B
(zh)
*
|
2020-03-05 |
2021-03-23 |
武汉科技大学 |
一种靶向hiv病毒囊膜双位点的嵌合抗原受体及其表达载体和应用
|
|
US12264190B2
(en)
*
|
2020-04-24 |
2025-04-01 |
Astrazeneca Ab |
Compositions and methods of treating cancer with chimeric antigen receptors
|
|
IL299764A
(en)
|
2020-07-10 |
2023-03-01 |
Precigen Inc |
Fusion constructs and methods for using them
|
|
KR102605723B1
(ko)
*
|
2020-11-11 |
2023-11-24 |
한국과학기술원 |
키메라 항원 수용체를 위한 타깃 항원 발굴 방법 및 분석 장치
|
|
CN114716548B
(zh)
*
|
2021-01-05 |
2024-11-05 |
(株)爱恩德生物 |
抗-fgfr3抗体及其用途
|
|
US20240327889A1
(en)
*
|
2021-04-05 |
2024-10-03 |
Victor TETS |
Regulation of cells and organisms
|
|
EP4319768A4
(en)
*
|
2021-04-08 |
2025-08-06 |
Artiva Biotherapeutics Inc |
CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-HER2 ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING IT
|
|
AU2022299551A1
(en)
|
2021-06-23 |
2024-01-18 |
Editas Medicine, Inc. |
Engineered cells for therapy
|
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
|
EP4388017A4
(en)
*
|
2021-08-20 |
2026-03-04 |
Christopher E Rudd |
COMPOSITIONS AND PROCESSES FOR ANTIVIRAL CHIMERIC ANTIGENIC RECEPTOR
|
|
CN119256075A
(zh)
|
2022-04-08 |
2025-01-03 |
菲特治疗公司 |
具有实体瘤靶向骨架的细胞及其用途
|
|
AU2023248529A1
(en)
|
2022-04-08 |
2024-10-24 |
Fate Therapeutics, Inc. |
Chimeric antigen receptor for tumor targeting
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
WO2025106453A1
(en)
*
|
2023-11-13 |
2025-05-22 |
California Institute Of Technology |
Synpoptosis circuits for programmable cell death control
|
|
CN119080932A
(zh)
*
|
2024-09-02 |
2024-12-06 |
浙江大学 |
靶向表皮生长因子受体耐药性突变体的西妥昔单抗变体
|